SmallCapReview.com is adding two small cap leaders to its Portfolio. Sanmina-SCI (Nasdaq: SANM) and Micrus Endovascular (Nasdaq: MEND) both profiles can be read at http://www.smallcapreview.com.

Sanmina-SCI Corporation (Nasdaq: SANM) $6.63. Announced yesterday after market close financial results for the fourth quarter and fiscal year ended October 3, 2009. Revenue of $1.35 billion, exceeded outlook of $1.2 - $1.3 billion. GAAP gross margin of 7 percent, 70 basis point sequential improvement. Non-GAAP gross margin of 7.1 percent, 70 basis point sequential improvement.